LyGenesis and Imagine Pharma to jointly develop cell therapies for Patients with Type 1 diabetes
Collaboration will enable rapid advancement of a joint preclinical proof of concept program for type 1 diabetes
Collaboration will enable rapid advancement of a joint preclinical proof of concept program for type 1 diabetes
CiRA, Kyoto University and Astellas - Second Phase Joint Research Agreement Signed for Medical Applications of iPS Cells
Bourgoin early development hub broadens offerings for oral solid dose formulations
Microsoft Cloud for Healthcare and Cognizant’s TriZetto healthcare products aim to enhance transparency for consumers and increase interoperability for providers and payers
The introduction of Octasa 1600 mg to the Canadian market is expected to increase the options for UC patients managed with mesalazine.
The milestone of operating continuously a very complex system for over two years has demonstrated the effectiveness of integrated laboratory automation solutions
Government hospitals like AIIMS, KGMC & many more as per day OPD patients are 18-25 thousand
Subscribe To Our Newsletter & Stay Updated